2 Private Lunar Landers | Cervical Cancer Deaths Plummet, Experts Credit HPV Vaccine

Cancer Decline

The introduction of the HPV vaccine in 2006 has led to a significant decline in cervical cancer rates among young women. Flora Lichtman highlights a study showing a 62% drop in cervical cancer deaths for women under 25, attributing this success primarily to the vaccine 1. Ashish Deshmukh explains that the vaccine covers multiple HPV strains, including those most responsible for cancer 2.

Cervical cancer is the type of HPV-associated cancers that occurs among young individuals.

--- Ashish Deshmukh

The expectation is that as vaccinated cohorts age, further declines in cervical cancer rates will be observed in older age groups 2.

   

Vaccine Hesitancy

Vaccine hesitancy remains a significant barrier to achieving higher HPV vaccination rates. Ashish Deshmukh notes that misconceptions about the vaccine being solely for sexually transmitted infections contribute to parental reluctance 3. He suggests rebranding it as a cancer prevention vaccine to shift perceptions and increase uptake.

We need to change the way we talk about HPV vaccine and think of this as a cancer prevention vaccine.

--- Ashish Deshmukh

Despite these challenges, the goal remains to vaccinate all eligible adolescents to prevent HPV-related cancers 3.

   

Global Goals

Global goals for HPV vaccination aim to eradicate HPV-related cancers through widespread coverage. Ashish Deshmukh emphasizes the vaccine's potential to prevent six types of cancers, calling it a public health revolution 4. He stresses the importance of achieving high vaccination rates worldwide, particularly in countries with high cervical cancer burdens like India and China 3.

It's special about HPV vaccine that it has the potential to eliminate all six cancer types.

--- Ashish Deshmukh

Efforts are underway to ensure adequate vaccine supply and screening infrastructure, especially in underserved communities 3.